BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23724143)

  • 21. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W; Liu Q; Jiang N; Li M; Shi L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.
    Chen CH; Lai JM; Chou TY; Chen CY; Su LJ; Lee YC; Cheng TS; Hong YR; Chou CK; Whang-Peng J; Wu YC; Huang CY
    PLoS One; 2009; 4(4):e5052. PubMed ID: 19337377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.
    Liu P; Zhou J; Zhu H; Xie L; Wang F; Liu B; Shen W; Ye W; Xiang B; Zhu X; Shi R; Zhang S
    Cytokine; 2011 Jul; 55(1):8-17. PubMed ID: 21482472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
    Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
    Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
    Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
    Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-493 Promotes Prostate Cancer Cells Proliferation by Targeting PHLPP2 and Activating Akt Signaling Pathway.
    Deng J; Ma M; Jiang W; Zhang H; Cui S
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868840
    [No Abstract]   [Full Text] [Related]  

  • 31. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
    Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
    Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
    Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
    Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
    Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through β-catenin/Snail/E-cadherin pathway.
    Guo L; Liu Z; Tang X
    Eur J Pharmacol; 2019 Nov; 862():172630. PubMed ID: 31472120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
    Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W
    Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells.
    Han L; Peng B; Ma Q; Ma J; Li J; Li W; Duan W; Chen C; Liu J; Xu Q; Laporte K; Li Z; Wu E
    Curr Med Chem; 2013; 20(33):4142-4152. PubMed ID: 23992308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
    Wang Y; Liu C; Xie Z; Lu H
    Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.